Tonga vs Upper middle income: Cause of death, by non-communicable diseases, female
Cause of death, by non-communicable diseases, female over time
- Tonga
- Upper middle income
How they compare
Tonga currently reports 85.9% against 76.6% in Upper middle income, a difference of 9.3%.
That makes Tonga's figure about 1.1 times Upper middle income's.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Tonga ahead.
Tonga ranks 12th and Upper middle income ranks 12th of 185 countries.
Across the 3 decades both report, Tonga averaged higher in 2 and Upper middle income in 1.
Head to head by decade
| Decade | Tonga | Upper middle income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.4% | 78.2% | 2.2% | Tonga |
| 2010s | 84.5% | 85.0% | 0.5% | Upper middle income |
| 2020s | 85.7% | 78.8% | 7.0% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Tonga or Upper middle income?
- Tonga, at 85.9% against 76.6% in Upper middle income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Tonga and Upper middle income?
- 9.3%, with Tonga ahead.
- How many years of comparable data are there for Tonga and Upper middle income?
- 6 years are reported by both, from 2000 to 2021.
- How do Tonga and Upper middle income rank globally for cause of death, by non-communicable diseases, female?
- Tonga ranks 12th and Upper middle income ranks 12th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.